These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 38310315)

  • 1. Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies.
    Ding X; He X; Tang B; Lan T
    Chin Med; 2024 Feb; 19(1):21. PubMed ID: 38310315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease.
    Zhou H; Ma C; Wang C; Gong L; Zhang Y; Li Y
    Eur J Pharmacol; 2021 May; 898():173976. PubMed ID: 33639194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review.
    Zheng S; Xue C; Li S; Zao X; Li X; Liu Q; Cao X; Wang W; Qi W; Zhang P; Ye Y
    Front Pharmacol; 2024; 15():1381712. PubMed ID: 38694920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis.
    Wu Q; Chen Z; Ding Y; Tang Y; Cheng Y
    Front Nutr; 2022; 9():1033129. PubMed ID: 36330148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives.
    Dai X; Feng J; Chen Y; Huang S; Shi X; Liu X; Sun Y
    Chin Med; 2021 Aug; 16(1):68. PubMed ID: 34344394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and treatment of non-alcoholic fatty liver disease by regulation of mitochondrial function with Chinese medicine].
    Ma Q; Shi AH; Zhao X; Chen WL
    Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5113-5120. PubMed ID: 36472018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention.
    Tacke F; Weiskirchen R
    Ann Transl Med; 2021 Apr; 9(8):729. PubMed ID: 33987427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions.
    Cusi K
    Diabetologia; 2016 Jun; 59(6):1112-20. PubMed ID: 27101131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis.
    Chen M; Xie Y; Gong S; Wang Y; Yu H; Zhou T; Huang F; Guo X; Zhang H; Huang R; Han Z; Xing Y; Liu Q; Tong G; Zhou H
    Pharmacol Res; 2021 Oct; 172():105849. PubMed ID: 34450307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine.
    Shao M; Lu Y; Xiang H; Wang J; Ji G; Wu T
    Front Pharmacol; 2022; 13():971561. PubMed ID: 36091827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug
    Ji L; Li Q; He Y; Zhang X; Zhou Z; Gao Y; Fang M; Yu Z; Rodrigues RM; Gao Y; Li M
    Acta Pharm Sin B; 2022 Sep; 12(9):3529-3547. PubMed ID: 36176915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.
    Zhou Z; Zhang J; You L; Wang T; Wang K; Wang L; Kong X; Gao Y; Sun X
    Front Endocrinol (Lausanne); 2022; 13():1000727. PubMed ID: 36204095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of ferroptosis in nonalcoholic fatty liver disease and therapeutic effects of traditional Chinese medicine: a review.
    Wang N; Que H; Luo Q; Zheng W; Li H; Wang Q; Gu J
    Front Med (Lausanne); 2024; 11():1356225. PubMed ID: 38590315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis.
    Le TA; Loomba R
    J Clin Exp Hepatol; 2012 Jun; 2(2):156-73. PubMed ID: 25755424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine models provide insight to the development of non-alcoholic fatty liver disease.
    Reid DT; Eksteen B
    Nutr Res Rev; 2015 Dec; 28(2):133-142. PubMed ID: 26494024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial.
    Xu J; Wang R; You S; Zhang L; Zheng P; Ji G; Liu B
    Trials; 2020 Jun; 21(1):512. PubMed ID: 32522273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease.
    Zhou L; Shen H; Li X; Wang H
    Front Immunol; 2022; 13():951406. PubMed ID: 35958574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.